
<document id="DBMI.pac16" origId="pac16">
	<sentence id="DBMI.pac16.s0" origId="s0" text="In three separate in vivo interaction studies, sertraline was co-administered with cytochrome P450 3A4 substrates, terfenadine, carbamazepine, or cisapride under steady-state conditions."/>
	<sentence id="DBMI.pac16.s1" origId="s1" text="The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride.">
		<entity charOffset="231-242" id="DBMI.pac16.s1.e0" origId="s1.e0" text="sertraline " type="Active ingredient"/>
		<entity charOffset="315-325" id="DBMI.pac16.s1.e1" origId="s1.e1" text="cisapride " type="Active ingredient"/>
		<entity charOffset="284-296" id="DBMI.pac16.s1.e2" origId="s1.e2" text="terfenadine " type="Active ingredient"/>
		<entity charOffset="297-311" id="DBMI.pac16.s1.e3" origId="s1.e3" text="carbamazepine " type="Active ingredient"/>
		<pair e1="DBMI.pac16.s1.e0" e2="DBMI.pac16.s1.e1" id="DBMI.pac16.s1.p0" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="cisapride " precipitant="sertraline "/>
		<pair e1="DBMI.pac16.s1.e0" e2="DBMI.pac16.s1.e2" id="DBMI.pac16.s1.p1" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="terfenadine " precipitant="sertraline "/>
		<pair e1="DBMI.pac16.s1.e0" e2="DBMI.pac16.s1.e3" id="DBMI.pac16.s1.p2" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="carbamazepine " precipitant="sertraline "/>
		<pair e1="DBMI.pac16.s1.e1" e2="DBMI.pac16.s1.e0" id="DBMI.pac16.s1.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.s1.e1" e2="DBMI.pac16.s1.e2" id="DBMI.pac16.s1.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.s1.e1" e2="DBMI.pac16.s1.e3" id="DBMI.pac16.s1.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.s1.e2" e2="DBMI.pac16.s1.e0" id="DBMI.pac16.s1.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.s1.e2" e2="DBMI.pac16.s1.e1" id="DBMI.pac16.s1.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.s1.e2" e2="DBMI.pac16.s1.e3" id="DBMI.pac16.s1.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.s1.e3" e2="DBMI.pac16.s1.e0" id="DBMI.pac16.s1.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.s1.e3" e2="DBMI.pac16.s1.e1" id="DBMI.pac16.s1.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.s1.e3" e2="DBMI.pac16.s1.e2" id="DBMI.pac16.s1.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentence id="DBMI.pac16.s2" origId="s2" text="These data indicate that sertralines extent of inhibition of P450 3A4 activity is not likely to be of clinical significance."/>
	<sentence id="DBMI.pac16.s3" origId="s3" text="Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.)induces the metabolism of cisapride (cisapride AUC and Cmax were reduced by about 35%).">
		<entity charOffset="514-525" id="DBMI.pac16.s3.e0" origId="s3.e0" text="sertraline " type="Active ingredient"/>
		<entity charOffset="490-500" id="DBMI.pac16.s3.e1" origId="s3.e1" text="cisapride " type="Active ingredient"/>
		<pair e1="DBMI.pac16.s3.e0" e2="DBMI.pac16.s3.e1" id="DBMI.pac16.s3.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="cisapride " precipitant="sertraline "/>
		<pair e1="DBMI.pac16.s3.e1" e2="DBMI.pac16.s3.e0" id="DBMI.pac16.s3.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentence>
	<sentencespan id="DBMI.pac16.sp0" origId="sp0" text="In three separate in vivo interaction studies, sertraline was co-administered with cytochrome P450 3A4 substrates, terfenadine, carbamazepine, or cisapride under steady-state conditions. The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride. These data indicate that sertralines extent of inhibition of P450 3A4 activity is not likely to be of clinical significance.">
		<entity charOffset="231-242" id="DBMI.pac16.sp0.e0" origId="sp0.e0" text="sertraline " type="Active ingredient"/>
		<entity charOffset="315-325" id="DBMI.pac16.sp0.e1" origId="sp0.e1" text="cisapride " type="Active ingredient"/>
		<entity charOffset="284-296" id="DBMI.pac16.sp0.e2" origId="sp0.e2" text="terfenadine " type="Active ingredient"/>
		<entity charOffset="297-311" id="DBMI.pac16.sp0.e3" origId="sp0.e3" text="carbamazepine " type="Active ingredient"/>
		<pair e1="DBMI.pac16.sp0.e0" e2="DBMI.pac16.sp0.e1" id="DBMI.pac16.sp0.p0" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="cisapride " precipitant="sertraline "/>
		<pair e1="DBMI.pac16.sp0.e0" e2="DBMI.pac16.sp0.e2" id="DBMI.pac16.sp0.p1" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="terfenadine " precipitant="sertraline "/>
		<pair e1="DBMI.pac16.sp0.e0" e2="DBMI.pac16.sp0.e3" id="DBMI.pac16.sp0.p2" interaction="true" interactionPhraseType="Qualitative" modality="Negative" object="carbamazepine " precipitant="sertraline "/>
		<pair e1="DBMI.pac16.sp0.e1" e2="DBMI.pac16.sp0.e0" id="DBMI.pac16.sp0.p3" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.sp0.e1" e2="DBMI.pac16.sp0.e2" id="DBMI.pac16.sp0.p4" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.sp0.e1" e2="DBMI.pac16.sp0.e3" id="DBMI.pac16.sp0.p5" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.sp0.e2" e2="DBMI.pac16.sp0.e0" id="DBMI.pac16.sp0.p6" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.sp0.e2" e2="DBMI.pac16.sp0.e1" id="DBMI.pac16.sp0.p7" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.sp0.e2" e2="DBMI.pac16.sp0.e3" id="DBMI.pac16.sp0.p8" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.sp0.e3" e2="DBMI.pac16.sp0.e0" id="DBMI.pac16.sp0.p9" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.sp0.e3" e2="DBMI.pac16.sp0.e1" id="DBMI.pac16.sp0.p10" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
		<pair e1="DBMI.pac16.sp0.e3" e2="DBMI.pac16.sp0.e2" id="DBMI.pac16.sp0.p11" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
	<sentencespan id="DBMI.pac16.sp1" origId="sp1" text="Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.)induces the metabolism of cisapride (cisapride AUC and Cmax were reduced by about 35%).">
		<entity charOffset="514-525" id="DBMI.pac16.sp1.e0" origId="sp1.e0" text="sertraline " type="Active ingredient"/>
		<entity charOffset="490-500" id="DBMI.pac16.sp1.e1" origId="sp1.e1" text="cisapride " type="Active ingredient"/>
		<pair e1="DBMI.pac16.sp1.e0" e2="DBMI.pac16.sp1.e1" id="DBMI.pac16.sp1.p0" interaction="true" interactionPhraseType="Quantitative" modality="Positive" object="cisapride " precipitant="sertraline "/>
		<pair e1="DBMI.pac16.sp1.e1" e2="DBMI.pac16.sp1.e0" id="DBMI.pac16.sp1.p1" interaction="false" interactionPhraseType="" modality="" object="" precipitant=""/>
	</sentencespan>
</document>
